PathoVax's Incubator/Accelerator Round

PathoVax raised a round of funding on February 24, 2016. Investors include MassCONNECT.

PathoVax is a biotech company developing a cost-effective human papillomavirus (HPV) vaccine machine with universal protection. PathoVax's pilot vaccine RGVax promises to provide protection against al…

Articles about PathoVax's Incubator/Accelerator Round: